New agents in non-small cell lung cancer
Authors:
- Rudolf A. JossRJRudolf A. Joss
- Franco CavalliFCFranco Cavalli
- Aron GoldhirschAGAron Goldhirsch
- Bernadette MermillodBMBernadette Mermillod
- Kurt W. BrunnerKBKurt W. Brunner
- 1 September 1984
- journal article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 11 (3) , 205-236
Abstract
No abstract availableThis publication has 42 references indexed in Scilit:
- Phase II study of 9-hydroxy-2N-methylellipticinium acetateEuropean Journal of Cancer and Clinical Oncology, 1984
- High-dose methotrexate with leucovorin rescue in patients with unresectable non-small cell carcinoma of the lungCancer, 1983
- A randomized phase II study of m-AMSA (NSC 249992) and neocarzinostatin (NSC 157365) in non-small cell broncliogenic carcinomaAmerican Journal of Clinical Oncology, 1983
- Clinical trials with the hexitol derivatives in the U.S.Cancer, 1981
- Clinical study of vincristine in adenocarcinoma of the lung: A study of the Early-Clinical-Trial Group of the E.O.R.T.C.European Journal of Cancer (1965), 1980
- Prognostic effect of weight loss prior tochemotherapy in cancer patientsThe American Journal of Medicine, 1980
- The Development of Mesna for the Inhibition of Urotoxic Side Effects of Cyclophosphamide, Ifosfamide, and Other Oxazaphosphorine Cytostatics1980
- Potential CNS Antitumor Agents VI: Aziridinylbenzoquinones IIIJournal of Pharmaceutical Sciences, 1979
- Synthesis and antitumor properties of new glycosides of daunomycinone and adriamycinoneJournal of Medicinal Chemistry, 1975
- Phase I study of high doses of methotrexate with citrovorum factor in patients with lung cancerCancer, 1972